CoNaIn recommends moving forward with the modification of the CNV by lowering the age of application of the second dose of SRP to 15-18 months. It suggests promoting actions to increase vaccination coverage of the first and second doses, reinforce the Epidemiological Surveillance of the EFE and move forward with the recovery of schemes to close gaps in each age cohort.

Recomendaciones de la OMS sobre uso de vacuna anti-influenza trivalente en sustitución de la tetravalente.

WHO recommendations on the use of trivalent anti-influenza vaccine instead of tetravalent.